Teladoc Health, Inc. Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ETCompany ParticipantsJason S. Brooks - Chairman, CEO & PresidentThomas D. Robertson - COO, CFO & TreasurerConference Call ParticipantsBruce Geller - Unidentified CompanyJanine Marie Hoffman Stichter - BTIG, LLC, Research DivisionJonathan Robert Komp - Robert W. Baird & Co. Incorporated, Research DivisionBrendon Frey - ICR Inc.OperatorGood afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the Rocky Brands Second Quarter 2025 Earnings Conference Call. [Operator Instructions] I would like to remind everyone that this conference call is being recorded.And I will now turn the conference over to Brendon Frey of ICR.Brendon FreyThank you, and thanks to everyone joining us today. Before we begin, please note that today's session, including the Q&A period, may contain forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such statements are based on information and assumptions available at this time and are subject to changes, risks and uncertainties, which may cause actual results to differ materially. We assume no obligation to update such statements. For a complete discussion of the risks and uncertainties, please refer to today's press release and our reports filed with the Securities and Exchange Commission, including our 10-K for the year ended December 31, 2024.I'll now turn the conference over to Jason Brooks, Chief Executive Officer of Rocky Brands. Jason?Jason S. BrooksThank you, Brendon. With me today is Tom Robertson, our Chief Operating and Chief Financial Officer. After our prepared remarks, we'll take your questions.We delivered very good Q2 results, significantly outperforming both last year and our own expectations through a strong execution across our diversified portfolio, high single-digit revenue growth and adjusted EPS that more than